Agile Therapeutics Inc. (AGRX)
NASDAQ: AGRX
· Real-Time Price · USD
1.51
0.05 (3.42%)
At close: Aug 22, 2024, 9:58 PM
Agile Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -11.87M | 1.28M | -4.47M | -798K | -3.81M | -5.39M | 18.24M | -19.66M | -12.22M | -11.77M | -23.36M | -16.77M | -17.64M | -17.13M |
Depreciation & Amortization | 102K | 103K | 100K | 98K | 95K | 93K | 91K | 262K | 593K | 588K | 575K | 552K | 550K | 546K |
Stock-Based Compensation | 285K | 333K | 563K | 439K | 481K | 498K | 524K | 536K | 669K | 764K | 866K | 887K | 843K | 742K |
Other Working Capital | n/a | n/a | 3.82M | 526K | 1.54M | -4.4M | -1.25M | -2.86M | 491K | -3.99M | -2.57M | 12.19M | 25.31M | 389K |
Other Non-Cash Items | n/a | 135K | 225K | 252K | 279K | -1.38M | -25.19M | 11.96M | 378K | 419K | 399K | 18.59M | 427K | 437K |
Deferred Income Tax | n/a | n/a | 931K | -3.53M | -1.67M | n/a | n/a | n/a | n/a | n/a | 3.91M | -16.77M | n/a | n/a |
Change in Working Capital | 2.57M | -128K | 2.82M | 3.9M | -3.89M | 4.58M | 4.77M | -9.8M | 7.64M | -4.75M | 991K | -5.06M | 481K | 735K |
Operating Cash Flow | 233K | -2.48M | 172K | 365K | -8.52M | -1.59M | -1.56M | -16.7M | -2.93M | -14.75M | -16.62M | -18.58M | -15.34M | -14.67M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -7K | -126K | -7K | -126K | -55K | -65K | -78K | -71K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -39.73M | 5M | 18.47M | 16.26M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | -133K | n/a | n/a | -126K | 39.73M | 5M | 18.47M | 16.26M |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | -7K | -126K | -7K | -126K | -55K | 4.93M | 18.39M | 16.18M |
Debt Repayment | n/a | -1.84M | -488K | -348K | -286K | -225K | -225K | -12.15M | n/a | -5M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 4.38M | n/a | -6.51M | 6.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 75K |
Financial Cash Flow | n/a | 2.54M | -487K | -278K | 6.88M | 778K | 660K | 9.82M | 12.22M | -523K | 21.08M | 2.26M | 6.59M | 484K |
Net Cash Flow | 233K | 59K | -316K | 88K | -1.64M | -817K | -899K | -6.88M | 9.28M | -15.4M | 4.41M | -11.38M | 9.65M | 2M |
Free Cash Flow | 233K | -2.48M | 172K | 365K | -8.52M | -1.59M | -1.57M | -16.83M | -2.94M | -14.88M | -16.67M | -18.64M | -15.41M | -14.74M |